List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 18 studies with search of: octanoic acid
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Octanoic Acid for Essential Tremor
Condition: Essential Tremor
Intervention: Drug: Octanoic Acid
2 Completed Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor
Condition: Essential Tremor
Intervention: Drug: Octanoic Acid
3 Recruiting Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Conditions: Metabolic Syndrome;   Nonalcoholic Fatty Liver Disease
Intervention: Drug: Sodium Octanoate
4 Not yet recruiting Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI
Conditions: Chronic Liver Disease;   Hepatocellular Carcinoma (HCC)
Intervention: Drug: 13C Sodium Octanoate
5 Recruiting Prediction of Severity of Liver Disease Non Alcoholic Fatty Liver Disease in Patients With Suspected NAFLD by a 13C Octanoate Breath Test
Condition: NAFLD
Intervention: Device: BreathID - Breath Test - 13C Octanoate
6 Completed Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Interventions: Drug: Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified;   Drug: Albumin (Human) 25%, USP
7 Not yet recruiting Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome
Conditions: Acute Myeloid Leukemia (AML);   Myelodysplastic Syndrome (MDS)
Intervention: Drug: CPI-613
8 Completed Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified;   Drug: Albumin (Human) 25%, USP
9 Completed Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified
10 Completed Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
Conditions: Immunologic Deficiency Syndrome;   Agammaglobulinemia;   Severe Combined Immunodeficiency;   Wiskott-Aldrich Syndrome;   Common Variable Immunodeficiency
Interventions: Drug: Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified;   Drug: Dextrose, 5% in Water
11 Completed Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified;   Drug: Albumin (Human) 25%, USP
12 Completed A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency
Condition: Immunologic Deficiency Syndrome
Intervention: Drug: Immune Globulin Intravenous (Human), 10%, Caprylate/Chromatography Purified
13 Completed Gastric and Intestinal Satiation in Obese and Normal Weight Healthy People
Condition: Endocrine System Diseases
Interventions: Dietary Supplement: ensure plus;   Dietary Supplement: standardized test meal
14 Completed Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance.
Conditions: Enteral Feeding Intolerance;   Gastroparesis
Interventions: Drug: GSK962040;   Drug: Placebo
15 Completed The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis.
Conditions: Diabetic Gastroparesis;   Gastroparesis
Intervention: Drug: GSK962040 or Placebo
16 Recruiting Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary Immunodeficiency
Condition: Primary Immunodeficiency
Intervention: Biological: GAMUNEX®-C
17 Completed Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention: Dietary Supplement: Medium chain fatty acid (Octanoic and Decanoic acid)
18 Completed Hexetidine and Chlorobutanol for Lesions Due to Prostheses
Condition: Oral Mucositis
Interventions: Drug: chlorobutanol, hexetidine;   Drug: Chlorhexidine

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services